# | Title | Journal | Year | Citations |
---|
|
1 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Blood | 2016 | 7,742 |
2 | The 2016 revision of the World Health Organization classification of lymphoid neoplasms | Blood | 2016 | 6,215 |
3 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] | Blood | 1994 | 6,172 |
4 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood | 2017 | 4,569 |
5 | International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes | Blood | 1997 | 4,113 |
6 | Human mesenchymal stem cells modulate allogeneic immune cell responses | Blood | 2005 | 4,076 |
7 | Biologic basis for interleukin-1 in disease | Blood | 1996 | 3,914 |
8 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Blood | 2009 | 3,905 |
9 | Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | Blood | 2004 | 3,652 |
10 | WHO-EORTC classification for cutaneous lymphomas | Blood | 2005 | 3,564 |
11 | A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis | Blood | 1996 | 3,017 |
12 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Blood | 2010 | 3,009 |
13 | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Blood | 2002 | 2,934 |
14 | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines | Blood | 2008 | 2,915 |
15 | Graft-versus-leukemia reactions after bone marrow transplantation | Blood | 1990 | 2,579 |
16 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes | Blood | 2012 | 2,578 |
17 | Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT | Blood | 2005 | 2,515 |
18 | Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome | Blood | 1975 | 2,479 |
19 | The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial | Blood | 1998 | 2,448 |
20 | Clinical staging of chronic lymphocytic leukemia | Blood | 1975 | 2,437 |
21 | Leukocyte-endothelial adhesion molecules | Blood | 1994 | 2,436 |
22 | A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma | Blood | 1997 | 2,408 |
23 | Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia | Blood | 1999 | 2,398 |
24 | Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia | Blood | 1999 | 2,313 |
25 | Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia | Blood | 1988 | 2,279 |
26 | Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group | Blood | 2009 | 2,214 |
27 | Current concepts in the diagnosis and management of cytokine release syndrome | Blood | 2014 | 2,181 |
28 | Nomenclature of monocytes and dendritic cells in blood | Blood | 2010 | 2,109 |
29 | Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors | Blood | 2000 | 2,101 |
30 | Interleukin-1 and interleukin-1 antagonism | Blood | 1991 | 2,059 |
31 | Improved survival in multiple myeloma and the impact of novel therapies | Blood | 2008 | 2,052 |
32 | Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments] | Blood | 1995 | 2,044 |
33 | Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis | Blood | 1994 | 2,021 |
34 | NADPH Oxidase: An Update | Blood | 1999 | 1,995 |
35 | COVID-19 and its implications for thrombosis and anticoagulation | Blood | 2020 | 1,975 |
36 | Adult T-cell leukemia: clinical and hematologic features of 16 cases | Blood | 1977 | 1,954 |
37 | Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments] | Blood | 1995 | 1,921 |
38 | The World Health Organization (WHO) classification of the myeloid neoplasms | Blood | 2002 | 1,916 |
39 | Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases | Blood | 1998 | 1,885 |
40 | International consensus report on the investigation and management of primary immune thrombocytopenia | Blood | 2010 | 1,853 |
41 | Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene | Blood | 2002 | 1,831 |
42 | Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 | Blood | 1994 | 1,822 |
43 | Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis | Blood | 1994 | 1,818 |
44 | The biology of interleukin-6 | Blood | 1989 | 1,809 |
45 | European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 | Blood | 2013 | 1,774 |
46 | Development and validation of a predictive model for chemotherapy-associated thrombosis | Blood | 2008 | 1,752 |
47 | Interleukin-1 in the pathogenesis and treatment of inflammatory diseases | Blood | 2011 | 1,739 |
48 | The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications | Blood | 2011 | 1,716 |
49 | HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Blood | 2006 | 1,702 |
50 | Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials | Blood | 2010 | 1,697 |